Results 41 to 50 of about 19,302 (239)

Exploring new avenues: Psychedelic‐assisted therapy for young people

British Journal of Clinical Pharmacology, EarlyView.
Rates of mental illness in young people are increasing, whereas the development of novel mental health treatments has not significantly progressed. Psychedelic‐assisted therapy, using substances such as psilocybin and 3,4‐methylenedioxymethamphetamine (MDMA), has shown potential in the treatment of mental illnesses in the adult population, including ...
Ioanna Artemis Vamvakopoulou, Dasha Nicholls, David J. Nutt, Martina Di Simplicio   +3 more
wiley   +1 more source

Clinical phenotypes of psychosis and reoffending risk among justice-involved adolescents: a population-based cohort study

Frontiers in Psychiatry
BackgroundHigh reoffending rates among justice-involved adolescents necessitate identifying modifiable risk factors. Given the elevated prevalence of psychosis in this group compared to the general adolescent population, determining its contribution ...
Emaediong I. Akpanekpo, Tony Butler
doaj   +1 more source

Relationships among nitrous oxide exposure, neurological injury and biomarkers

British Journal of Clinical Pharmacology, EarlyView.
Aims Recreational nitrous oxide (N2O) misuse is an increasing public health problem associated with functional cobalamin (B12) deficiency and severe neurological complications. Despite growing recognition of its harms, the dose–response relationship and clinical value of biomarkers remain unclear.
Laxna Bhujel, Angela L. Chiew, Bhashita Jagarlamudi, Pramod Chandru, Naren Gunja, Nancy Briggs, Betty S. Chan   +6 more
wiley   +1 more source

Prevalence of schizophrenia spectrum and bipolar disorder among patients with cannabis induced psychosis: a systematic review and meta-analysis

BMC Psychiatry
Background Distinguishing cannabis-induced psychosis from primary psychiatric disorders is difficult and has significant clinical and prognostic implications.
Mohammad Saad Javed, Rayane El-Khoury, Amr Ahmed Taha, Shuja Mohd Reagu   +3 more
doaj   +1 more source

The Prevalence of Substance Induced Psychosis & Substance Induced Mood Disorders in Adolescent Population

European Psychiatry, 2009
Introduction:Drug and alcohol addiction is a leading cause of raising health care cost and has adverse effect on peoples health, social and occupational functioning.The purpose of this study was to investigate the prevalence of substance induced psychosis and mood disorders in adolescent population, and to determine what type of substance causing the ...
S. Aldandashi, M. Blackman
openaire   +1 more source

Psychopathology in Substance Use Disorder Patients with and without Substance-Induced Psychosis [PDF]

Journal of Addiction, 2015
Background. Substance-induced psychotic disorder (SIPD) is a diagnosis constructed to distinguish substance-induced psychotic states from primary psychotic disorders. A number of studies have compared SIPD persons with primary psychotic patients, but there is little data on what differentiates substance use disorder (SUD) individuals with and without ...
Zhornitsky, Simon, Tikàsz, Andràs, Rizkallah, Élie, Chiasson, Jean-Pierre, Potvin, Stéphane   +4 more
openaire   +3 more sources

Pharmacogenomics of dolutegravir: A scoping review of evidence, gaps and clinical implications

British Journal of Clinical Pharmacology, EarlyView.
Dolutegravir underpins modern first‐ and second‐line HIV treatment regimens; however, interindividual variability in its disposition and tolerability presents challenges for optimal use. This scoping review mapped current evidence on the pharmacogenomics of dolutegravir, focusing on pharmacokinetics and pharmacodynamics, and methodological limitations ...
Ronald Kiguba, Mishael Ssesanga, Munir Pirmohamed   +2 more
wiley   +1 more source

Reversible worsening of psychosis due to benzydamine in a schizoaffective young girl who is already under treatment with antipsychotics

Psychiatry and Clinical Psychopharmacology, 2021
Benzydamine, available as the hydrochloride form, is an anti-inflammatory drug providing both rapid and extended pain relief in many painful inflammatory conditions.
Mehmet Kerem Doksat
doaj  

An ETH‐LAD trip with unfavourable consequences: A case report

British Journal of Clinical Pharmacology, EarlyView.
Numerous analogues of the psychedelic and internationally controlled hallucinogen LSD have been described; however, only a limited number have been systematically investigated. This report presents the first case with an analytically confirmed ingestion of ETH‐LAD (6‐ethyl‐6‐nor‐lysergic acid diethylamide), the N‐ethyl derivative of LSD.
Johannes Nadler, Michaela Sommer, Annette Zschiesche, Anne Stürzebecher, Christina Grumann, Volker Auwärter, Maren Hermanns‐Clausen   +6 more
wiley   +1 more source

A case of steroid induced psychosis in a patient with mediastinal lymphoma

European Psychiatry
Introduction Corticosteroids are a key part of many cancer treatment regimens and neuropsychiatric side effects have long been recognised. Steroid-induced psychosis is a disorder classified under substance or medication-induced psychosis in the ...
B. Orgaz Álvarez, M. Velasco Santos, P. Ibáñez Mendoza, Á. de Vicente Blanco, G. García Cepero   +4 more
doaj   +1 more source